Comparison of mismatch repair status between primary and matched metastatic sites in patients with colorectal cancer.

被引：0
|
作者：
He, Wen-Zhuo
Hu, Wan-ming
Jiang, Chang
Xia, Xiao-jun
Xia, Liang-ping
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Guangdong, Peoples R China
[2] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
[3] Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.3563
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3563
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Comparison between the three oxaliplatin-based regimens with bevacizumab in patients with metastatic colorectal cancer.
    Ohhara, Yoshihito
    Suenaga, Mitsukuni
    Matsusaka, Satoshi
    Shinozaki, Eiji
    Mizunuma, Nobuyuki
    Yamaguchi, Toshiharu
    Hatake, Kiyohiko
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [32] Comparison of PD-L1 expression and MMR status between primary and matched metastatic lesions in patients with cervical cancer
    Huizhen Liu
    Lixin Sun
    Jing Lian
    Lixia Wang
    Yanfeng Xi
    Guohai Zhao
    Jiahong Wang
    Xiaoyu Lan
    Haiyan Du
    Wenxia Yan
    Peng Bu
    Ping Wang
    Anna Moore
    Hongwei Zhao
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 11397 - 11410
  • [33] Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer
    Quiroga, Dionisia
    Lyerly, H. Kim
    Morse, Michael A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (08)
  • [34] Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer
    Dionisia Quiroga
    H. Kim Lyerly
    Michael A. Morse
    Current Treatment Options in Oncology, 2016, 17
  • [35] Comparison of immunological characteristics between paired mismatch repair-proficient and -deficient colorectal cancer patients
    Shou-Sheng Liu
    Yuan-Zhong Yang
    Chang Jiang
    Qi Quan
    Qian-Kun Xie
    Xiao-Pai Wang
    Wen-Zhuo He
    Yu-Ming Rong
    Ping Chen
    Qiong Yang
    Lin Yang
    Bei Zhang
    Xiao-Jun Xia
    Peng-Fei Kong
    Liang-Ping Xia
    Journal of Translational Medicine, 16
  • [36] Response to pembrolizumab in patients with mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC).
    Leal, Alexis Diane
    Paludo, Jonas
    Finnes, Heidi D.
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [37] Comparison of immunological characteristics between paired mismatch repair-proficient and -deficient colorectal cancer patients
    Liu, Shou-Sheng
    Yang, Yuan-Zhong
    Jiang, Chang
    Quan, Qi
    Xie, Qian-Kun
    Wang, Xiao-Pai
    He, Wen-Zhuo
    Rong, Yu-Ming
    Chen, Ping
    Yang, Qiong
    Yang, Lin
    Zhang, Bei
    Xia, Xiao-Jun
    Kong, Peng-Fei
    Xia, Liang-Ping
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [38] Characteristics and survival of metastatic colorectal cancer patients receiving local treatment with deficient mismatch repair versus proficient mismatch repair
    Roodhart, J.
    Zwart, K.
    Punt, C. J. A.
    Wensink, E.
    Bolhuis, K.
    Lacle, M. M.
    van Grevenstein, W.
    Hagendoorn, J.
    de Hingh, I. H. J. T.
    Koopman, M.
    Vink, G.
    van der Baan, F.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S704 - S705
  • [39] Meta Analysis of Discordant HER2 Status in Matched Primary and Metastatic Breast Cancer.
    Richter, S.
    Zandvakili, A.
    CANCER RESEARCH, 2011, 71
  • [40] Relatively High Discordant Rate of KRas Mutation Between Primary and Metastatic Sites, and a Different Pattern of KRas Mutational Status According to Metastatic Sites in Korean Patients With Colorectal Cancer
    Kim, M. J.
    Lee, K. W.
    Lee, H. S.
    Kim, J. H.
    Kim, Y. J.
    Kwon, J. H.
    Kim, D. W.
    Kang, S. B.
    Choi, I. S.
    Lee, J. S.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S433 - S433
12345